A genetic predisposition to having lower insulin production and less healthy fat distribution are major causes of early-onset type 2 diabetes in British Asian people.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy Tuesday! Adam Feuerstein,
Good morning, everyone, and how are you today? We are doing just fine, thank you, despite a spot of rain and accompanying gloomy clouds hovering
The Biden administration announced Tuesday that it’s proposing a number of changes to private Medicare plans designed to alleviate coverage barriers, put guardrails around the
Imagine gradually losing the ability to express yourself -; not because you’ve forgotten the words, but because they simply won’t come out.
Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases
Neonatal diabetes mellitus affects an estimated 300 individuals in the US. Credit: July Semianovich/Shutterstock. Eton Pharmaceuticals has acquired the US rights to Amglidia, a treatment
(Editor’s note: In her first draft of this article, Dr. Alaina Jaster did not include herself, despite the central role she has played in challenging
The Office for Civil Rights is not checking whether health care providers and other people who handle Americans’ sensitive data are complying with federal health
Shares in Roche opened 0.55% lower at market open following the news. Image credit: Shutterstock / Marlon Trottmann. Roche’s struggles with finding a foothold for